Bioprocessing Sponsored by MilliporeSigma
Thermo Fisher set to acquire Qiagen after all in $11.5B deal
After an on-and-off courtship, Thermo Fisher Scientific announced it is set to acquire Qiagen in a deal worth $11.5 billion. The transaction will give Thermo Fisher access to Qiagen's molecular diagnostics expertise and potentially lead to faster development of diagnostic tests.
Glia-to-neuron conversion gene therapy can treat Huntington's disease
Using adeno-associated virus technology, researchers have developed a novel gene therapy that can regenerate functional neurons in mouse models of Huntington's disease. The work was published in Nature Communications on February 27.  Discuss
Sanofi to establish new API company in Europe
French pharmaceutical developer Sanofi announced on February 24 that it plans to expand operations by establishing a new independent company to target the active pharmaceutical ingredient (API) market in Europe.
FDA enhances Purple Book with biosimilars upgrade
The U.S. Food and Drug Administration (FDA) will be upgrading the Purple Book, a database of FDA-licensed biological products, beginning on February 24. Early-phase upgrades will include full search functionality for all biosimilar products and their reference products.
Florida CRO expands drug screening and manufacturing
Florida-based contract research organization (CRO) Alchem Laboratories is constructing a new building to grow its screening and chemical trail manufacturing capabilities.
Microscale flow chemistry uses 'switchable solvents' to improve extraction
New green technology enables accelerated screening and retrieval of "switchable" solvents for chemical and pharmaceutical applications. Utilizing microfluidic strategies, researchers developed an in situ approach to study gas-liquid processes in a time- and material-efficient manner. The work was published online in ACS Sustainable Chemistry and Engineering on February 6.  Discuss
Audentes plans gene therapy facility in NC
Audentes Therapeutics has announced that it plans to invest $109 million to build a new 135,00-sq-ft gene therapy manufacturing facility in Sanford, NC, that is expected to be operational by 2021.
MilliporeSigma to make Elypta liquid biopsy kits
MilliporeSigma has signed an agreement with Swedish molecular diagnostics company Elypta to be the contract manufacturer for Elypta's clinical diagnostic liquid biopsy kits.
Thermo Fisher, NanoPin partner on infectious disease tech
Thermo Fisher Scientific will partner with infectious diseases diagnostic company NanoPin Technologies to develop workflows for liquid chromatography-mass spectrometry.
Bioprocessing Summit Europe to be held March 24-26
The Bioprocessing Summit Europe will return to Barcelona, Spain, this year to address the growing global market for gene therapy and biopharmaceutical manufacturing. The summit will take place from March 24 to 26.
Conferences
BioProcess International Europe
April 28 - May 1
Amsterdam, Noord-Holland Netherlands
Lab of the Future USA
May 19-20
Boston, Massachusetts United States
2nd Annual Cell Therapy Bioprocessing Conference
June 25-26
Boston, Massachusetts United States
BioProcess International
September 21-24
Boston, Massachusetts United States
General Discussion
Topic Replies / Views Last Update
Open science for the modern scientific community
by LMoraes
3 / 53 More than 3 days ago
by The Mets
https://academic.oup.com/ve/pages/coronavirus-evolution
by Michael
0 / 14 More than 3 days ago
by Michael
PopSci Hails Impossible Burger 2.0 as Most Important Engineering Innovation in 2019
by Mahesh Gupta
0 / 8 More than 3 days ago
by Mahesh Gupta
Engineered Bacteria Produces BeeFree Honey
by Mahesh Gupta
0 / 11 More than 3 days ago
by Mahesh Gupta
Consumers' Preference to Buy Unlabeled Produce Increases after Exposure to GMO-labeled Pro
by Mahesh Gupta
0 / 14 More than 3 days ago
by Mahesh Gupta
To see more posts from our community or to share a post of your own, go to our community's forum page.
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter